A biotech founded by a 32-year-old just failed a key Alzheimer's drug trial - Business Insider (press release) (registration) (blog)

Business Insider (press release) (registration) (blog)

A biotech founded by a 32-year-old just failed a key Alzheimer's drug trial Business Insider (press release) (registration) (blog) Axovant, a company founded by 32-year-old Vivek Ramaswamy, just failed a key late-stage trial for its Alzheimer's drug. Axovant is the latest in a series of failures to get an Alzheimer's drug approved. 99% of all Alzheimer's drugs have failed clinical ... and more »

from Health - Google News http://ift.tt/2xJbNLO